Olema Pharmaceuticals, Inc.(OLMA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | -40,000 | -98.47%233 | $23.79 | $951,503 | View SEC filing | |
| 2026-01-21 | Harmon Cyrus Director | Sale | -10,000 | -1.17%844,798 | $26.88 | $268,800 | View SEC filing | |
| 2026-01-16 | Harmon Cyrus Director | Sale | -3,489 | -0.41%854,798 | $29.12 | $101,600 | View SEC filing | |
| 2026-01-15 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | -103,822 | -42.63%139,727 | $28.70 | $2,980,054 | View SEC filing | |
| 2026-01-14 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | -110,000 | -13.57%700,438 | $28.25 | $3,107,229 | View SEC filing | |
| 2025-12-29 | Harmon Cyrus Director | Sale | -2,881 | -0.33%858,287 | $28.53 | $82,195 | View SEC filing | |
| 2025-12-23 | Zojwalla Naseem Chief Medical Officer | Sale | -269,509 | -98.36%4,488 | $27.94 | $7,530,148 | View SEC filing | |
| 2025-12-23 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | -51,000 | -6.70%710,558 | $30.46 | $1,553,544 | View SEC filing | |
| 2025-12-23 | CLARK IAN T Director | Sale | -264,800 | -100.00%0 | $29.73 | $7,873,109 | View SEC filing | |
| 2025-09-18 | Harmon Cyrus Director | Sale | -25,000 | -2.82%861,168 | $8.19 | $204,841 | View SEC filing | |
| 2025-01-13 | Bain Capital Life Sciences Investors, LLC 10% Owner | Purchase | +300,000 | +4.00%7,800,000 | $5.76 | $1,727,370 | View SEC filing | |
| 2024-12-18 | Graham G. Walmsley Director | Mixed | 0 | +0.00%1,408,875 | $6.75 | $9,460,274 | View SEC filing | |
| 2024-12-17 | Graham G. Walmsley Director | Mixed | -1,401,522 | -49.87%1,408,875 | $6.75 | $9,460,274 | View SEC filing | |
| 2024-12-11 | Harmon Cyrus Director | Sale | -16,393 | -1.82%886,168 | $9.03 | $147,956 | View SEC filing | |
| 2024-12-11 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | -26,066 | -3.29%766,010 | $9.01 | $234,916 | View SEC filing | |
| 2024-12-11 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | -27,805 | -19.40%115,509 | $9.01 | $250,456 | View SEC filing | |
| 2024-12-11 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | -35,159 | -6.08%543,549 | $9.01 | $316,703 | View SEC filing | |
| 2024-12-11 | Bohen Sean PRESIDENT AND CEO | Sale | -109,502 | -31.18%241,662 | $9.01 | $986,365 | View SEC filing | |
| 2024-11-26 | Graham G. Walmsley Director | Sale | -1,175,000 | -45.47%1,408,875 | $14.85 | $17,448,750 | View SEC filing | |
| 2024-08-05 | Paradigm BioCapital International Fund Ltd. 10% Owner | Sale | -2,400,000 | -30.37%5,503,600 | $14.91 | $35,796,000 | View SEC filing | |
| 2024-07-31 | Harmon Cyrus Director | Sale | -5,000 | -0.57%873,311 | $15.57 | $77,872 | View SEC filing | |
| 2024-07-12 | Harmon Cyrus Director | Sale | -5,000 | -0.57%878,311 | $12.26 | $61,300 | View SEC filing | |
| 2024-07-02 | Harmon Cyrus Director | Sale | -20,000 | -2.21%883,311 | $10.77 | $215,400 | View SEC filing | |
| 2024-06-06 | Graham G. Walmsley Director | Sale | -1,175,000 | -45.47%1,408,875 | $14.85 | $17,448,750 | View SEC filing | |
| 2024-06-04 | Harmon Cyrus Director | Sale | -25,000 | -2.69%903,311 | $10.30 | $257,450 | View SEC filing |
1-25 of 81